Daniel Ermann, MD, discusses data for real-world treatment burdens among older patients with chronic lymphocytic leukemia.
Back
Investigating Treatment Burden Patterns in Older Patients With CLL/SLL
Daniel A. Ermann, MD, and colleagues evaluated treatment burden based on age in chronic lymphocytic leukemia.
Investigating Treatment Burden Patterns in Older Patients With CLL/SLL
Episodes
All
All
A retrospective analysis of 3234 patients with CLL/SLL showed that over half of those 75 to 79 years of age went on to receive second-line therapy.
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer
2
FDA Flashback: Breast Cancer Decisions and News From July 2026
3
Dostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC
4
Dr Brufsky on the FDA Approval of Gedatolisib Plus Fulvestrant ± Palbociclib in PIK3CA Wild-Type Breast Cancer
5